Don2 (Don1 Revised)
Contributor
Article
That sounds too reasonable and so maybe they will reduce it to $800 after some pressure.
Ozempic could be profitably produced for less than $5 a month even as maker Novo Nordisk A/S charges almost $1,000 in the US, according to a study that revives questions about prices for top-selling treatments for diabetes and obesity.
The blockbuster drug could be manufactured for 89 cents to $4.73 for a month’s supply, figures that include a profit margin, researchers at Yale University, King’s College Hospital in London and the nonprofit Doctors Without Borders reported in the journal JAMA Network Open. That compares to the monthly US list price of $968.52 for Ozempic, a weekly injection.
...
Bernie Sanders ... called on Novo Nordisk to lower the list price of Ozempic to $155 a month or less, in line with what it charges in other countries.
That sounds too reasonable and so maybe they will reduce it to $800 after some pressure.